Upper extremities deep vein thrombosis treated with oral direct anticoagulants: A prospective cohort study-Reference-Cited by-同舟云学术

Upper extremities deep vein thrombosis treated with oral direct anticoagulants: A prospective cohort study

Published:2021-09 Issue: Volume:339 Page:158-163
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Vedovati Maria Cristina,Tratar Gregor,Mavri Alenka,Mazzetti Matteo,Salazar Rosa Vladimir,Pierpaoli Lucia,Cotugno Marilena,Agnelli Giancarlo,Becattini Cecilia

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference28 articles.

1. Upper extremity deep venous thrombosis in the population-based Malmö Thrombophilia Study (MATS): epidemiology, risk factors, recurrence risk, and mortality;Isma;Thromb. Res.,2010

2. Upper-extremity deep vein thrombosis: a prospective registry of 592 patients;Joffe;Circulation,2004

3. Clinical outcome of patients with upperextremity deep vein thrombosis: results from the RIETE Registry;Muñoz;Chest,2008

4. Clinical practice. Deep-vein thrombosis of the upper extremities;Kucher;N. Engl. J. Med.,2011

5. A comprehensive review of Paget-Schroetter syndrome;Illig;J. Vasc. Surg.,2010

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer‐associated venous thrombosis in adults (second edition): A British Society for Haematology Guideline;British Journal of Haematology;2024-04-25

2. A systematic review and meta-analysis of the incidence of post-thrombotic syndrome, recurrent thromboembolism, and bleeding after upper extremity vein thrombosis;Journal of Vascular Surgery: Venous and Lymphatic Disorders;2024-01

3. Risk and Prognosis of Upper Extremity Deep Vein Thrombosis;Annals of Vascular Diseases;2023-09-25

4. Low-dose apixaban or rivaroxaban as secondary prophylaxis of upper extremity deep vein thrombosis;Journal of Thrombosis and Thrombolysis;2023-06-21

5. The 5 most frequently asked questions about factor Xa inhibitors;HEMATOL-AM SOC HEMAT;2022